Other News

New Rapid Cardiac MR Imaging Helps Detect and Manage Patient Heart Health During and After Cancer Treatments

United Imaging now preferred medical imaging partner for MyoStrain® and its unique diagnostic cardiac test. HOUSTON, Aug. 5, 2020 /PRNewswire/ — United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, along with Myocardial Solutions, a medical technology company working to transform the cardiac and cancer care continuum, announced today […]

CardioMech AS Announces $18.5M Series A for its Transcatheter Mitral Valve Repair Technology

The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech’s journey to treat patients in a first-in-human feasibility trial MINNEAPOLIS, Aug. 5, 2020 /PRNewswire/ — Minneapolis based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve repair technology, announced today it […]

National Survey Of Heart Valve Patients Reveals Importance Of Seeking Treatment Early With Active Living As Key Priority

New awareness campaign empowers patients to proactively manage treatment decisions as fears of hospital visits increase during COVID-19 TORRANCE, Calif., Aug. 5, 2020 /PRNewswire/ — A national survey released today by patient advocacy group Heart-Valve-Surgery.com with support by Medtronic, found that nearly half (49 percent) of heart valve patients say return to active […]

Liquidia Releases Exploratory Endpoint Data from INSPIRE Study at the American Thoracic Society (ATS) Annual Meeting

New data from INSPIRE LIQ861 safety and tolerability study in pulmonary arterial hypertension (PAH) patients demonstrate positive trends in exploratory endpoints, including quality of life (QoL) RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development […]

Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results

WARREN, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2020. “Bellerophon has […]

Endologix Receives CE Mark for ALTO Abdominal Stent Graft System

IRVINE, Calif.–(BUSINESS WIRE)–Transforming the treatment of aortic disorders, Endologix® Inc. (OTC: ELGXQ) (“Endologix” or the “Company”), today announced that it has received a CE Mark for the ALTO™ Abdominal Stent Graft System (ALTO). “We are very excited to receive a CE Mark for the ALTO system, that has been achieved through […]

NorthShore University HealthSystem, Carnegie Mellon University and PhysIQ Launch Comprehensive Study of New Technology to Monitor At-Risk Cardiac and Surgical Patients

CHICAGO–(BUSINESS WIRE)–NorthShore University HealthSystem (NorthShore), Carnegie Mellon University, and physIQ are collaborating on a multi-phase pilot project using the pinpointIQ™ solution to manage patients with heart failure and patients undergoing ileostomy. These patient populations historically have significant clinical risks when transitioning from the hospital to home. Using this solution, NorthShore will be able […]